Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dermira Inc (DERM)

Dermira Inc (DERM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
SHAREHOLDER ALERT: WeissLaw LLP Reminds HABT, DERM, and MFSF Shareholders About Its Ongoing Investigations

EQNX::TICKER_START (NASDAQ:HABT),(NASDAQ:DERM),(NasdaqGM:MFSF),(NASDAQ:NWBI), EQNX::TICKER_END

HABT : 13.95 (unch)
DERM : 18.71 (-0.27%)
MFSF : 38.31 (-0.83%)
NWBI : 16.17 (-0.89%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - CBB, HABT, DERM, IBKC

Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

CBB : 13.75 (+22.22%)
HABT : 13.95 (unch)
DERM : 18.71 (-0.27%)
IBKC : 74.93 (-2.75%)
DERM, CRCM, LOGM, and WAAS SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

Rigrodsky & Long, P.A. announces that it is investigating:

DERM : 18.71 (-0.27%)
LOGM : 86.30 (+0.01%)
CRCM : 14.97 (-0.07%)
WAAS : 26.89 (-0.19%)
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Dermira, Primo Water, Hexcel, and Pope Resources on behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Dermira, Inc. (NASDAQ: DERM), Primo Water Corporation (NASDAQ: PRMW), Hexcel Corporation...

DERM : 18.71 (-0.27%)
PRMW : 14.75 (+0.07%)
HXL : 74.22 (-0.31%)
POPE : 122.68 (-2.25%)
Moore Kuehn, PLLC Encourages PRMW, DERM, CBB, and HABT Investors to Contact Firm

Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders....

PRMW : 14.75 (+0.07%)
DERM : 18.71 (-0.27%)
CBB : 13.75 (+22.22%)
HABT : 13.95 (unch)
Lilly to Buy Dermira for $1.1B, Add Phase III Eczema Candidate

Lilly (LLY) offers to buy Dermira for $1.1 billion to add the latter's late-stage candidate for atopic dermatitis/eczema, lebrikizumab.

SNY : 48.73 (-1.75%)
LLY : 139.07 (-1.52%)
REGN : 345.28 (-3.17%)
DERM : 18.71 (-0.27%)
Grubhub, Six Flags fall, Nektar, Infosys rise

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Friday:

DERM : 18.71 (-0.27%)
LLY : 139.07 (-1.52%)
INFY : 11.03 (-0.27%)
URBN : 26.22 (-0.94%)
SIX : 37.68 (+1.07%)
SNX : 142.78 (-1.26%)
GRUB : 58.57 (+1.44%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Dermira, Inc.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Dermira, Inc. ("DERM" or the "Company") (NASDAQ: DERM) in connection with the...

DERM : 18.71 (-0.27%)
LLY : 139.07 (-1.52%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of DERMIRA, INC. - DERM

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Dermira, Inc. ("Dermira"...

LLY : 139.07 (-1.52%)
DERM : 18.71 (-0.27%)
DERMIRA MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Dermira, Inc. is Fair to Shareholders; Investors are Encouraged to Contact the Firm - DERM

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Dermira, Inc. (NASDAQ: DERM) to Eli Lilly and Company ("Eli Lilly") for $18.75 per share is fair to Dermira shareholders....

LLY : 139.07 (-1.52%)
DERM : 18.71 (-0.27%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Dermira, Inc.

Rowley Law PLLC is investigating potential securities law violations by Dermira, Inc. (NASDAQ: DERM) and its board of directors concerning the proposed acquisition of the company by Eli Lilly and Company...

DERM : 18.71 (-0.27%)
LLY : 139.07 (-1.52%)
The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences

The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences

AIRI : 1.85 (+8.19%)
DERM : 18.71 (-0.27%)
AGRX : 3.35 (+8.77%)
MBOT : 10.33 (-7.93%)
SAVA : 7.18 (-7.18%)
(DERM) Alert: Johnson Fistel Investigates Proposed Sale of Dermira, Inc.; Is $19.30 a Fair Price?

Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Dermira, Inc. (NASDAQ: DERM) ("Dermira") breached their fiduciary duties in connection with...

LLY : 139.07 (-1.52%)
DERM : 18.71 (-0.27%)
Lilly Announces Agreement to Acquire Dermira

Eli Lilly and Company (NYSE: LLY) and Dermira, Inc. (NASDAQ: DERM) today announced a definitive agreement for Lilly to acquire Dermira for $18.75 per share, or approximately $1.1 billion, in an all-cash...

LLY : 139.07 (-1.52%)
DERM : 18.71 (-0.27%)
Buy Multibagger Stocks as Odds of a Rally Are High in 2020

Multibagger stocks can make most of the bull run, courtesy of strong fundamentals and businesses that can multiply in a short span of time.

AIRI : 1.85 (+8.19%)
DERM : 18.71 (-0.27%)
AGRX : 3.35 (+8.77%)
MBOT : 10.33 (-7.93%)
SAVA : 7.18 (-7.18%)
Pacira's (PCRX) Exparel Meets Key Goals in C-Section Study

Pacira's (PCRX) phase IV CHOICE study on its lead drug Exparel in patients undergoing Cesarean section attains the primary as well as key secondary endpoints.

JNJ : 148.32 (-0.14%)
DERM : 18.71 (-0.27%)
PCRX : 43.81 (-0.30%)
VRCA : 15.29 (-9.31%)
Moving Average Crossover Alert: Dermira

Dermira, Inc. (DERM) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

DERM : 18.71 (-0.27%)
Will Dermira Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Dermira.

DERM : 18.71 (-0.27%)
Relatively Good Performance Detected in Shares of Dermira in the Pharmaceuticals Industry (DERM , MDCO , BMY , MRK , ZTS )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

BMY : 64.16 (-4.05%)
DERM : 18.71 (-0.27%)
MDCO : 84.90 (-0.07%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (DERM , AERI , MYL , MRK , LLY )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

AERI : 21.50 (-4.70%)
DERM : 18.71 (-0.27%)
MYL : 21.85 (-1.31%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -2.85 , SEDG +1.40 , THC -1.96 , TER -4.11 , LITE -0.55
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar